Thursday, October 13, 2011 4:54:39 AM
Maxxon, Inc is stepping into a $3 billion dollar market for disposable syringes with their product - the Maxxon Safety Syringe. This company has recently signed a letter of intent to acquire an exclusive worldwide license to manufacture and market a patented disposable syringe with automatic needle retraction. Over 300 healthcare employees die annually from needlestick injuries and Maxxon is poised with their product to solve this problem.
Shares outstanding: 8,353,000 Float: 475,000
MAXXON, INC (MXON.Nasdaq BB) Disposable syringe technology
Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • BLO • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM